E-LIB Suche - Ergebnisse für: Poklepovic, Andrew S.

1

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Adva..:

Patel, Sapna P ; Othus, Megan ; Chen, Yuanbin...
qt87x612c2. , 2023

Link: https://escholarship.org..

2

Immunologically programming the tumor microenvironment indu..:

Yu, Xiaofei ; Liu, Wenjie ; Chen, Shixian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817794/. , 2021

Link: http://www.ncbi.nlm.nih...

3

A Multi-Institutional Phase 2 Trial of Regorafenib in Refra..:

Kim, Richard D ; Sanoff, Hanna K ; Poklepovic, Andrew S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787270/. , 2020

Link: http://www.ncbi.nlm.nih...

4

Considering adjuvant therapy for stage II melanoma:

Poklepovic, Andrew S ; Luke, Jason J
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065103/. , 2019

Link: http://www.ncbi.nlm.nih...

5

777 Initial results from an open-label phase 1b/2 study of ..:

Gregory A Daniels ; Diwakar Davar ; Theresa Medina...
https://doaj.org/toc/2051-1426. , 2023

Link: https://doi.org/10.1136/..

6

778 TILVANCE-301, a phase 3 study of lifileucel tumor-infil..:

Gino K In ; James Larkin ; Yazan Samhouri...
https://doaj.org/toc/2051-1426. , 2023

Link: https://doi.org/10.1136/..

7

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in ..:

Stacey A. Cohen ; Anup Kasi ; Nicole Hook...
http://dx.doi.org/10.1155/2022/9412201. , 2022

Link: https://doi.org/10.1155/..

8

Immunologically programming the tumor microenvironment indu..:

Elizabeth Repasky ; Harry D Bear ; Fang Yuan...
https://jitc.bmj.com/content/9/1/e001595.full. , 2021

Link: https://doi.org/10.1136/..

9

BMI, irAE, and gene expression signatures associate with re..:

Brian W. Labadie ; Ping Liu ; Riyue Bao...
http://link.springer.com/article/10.1186/s12967-019-02144-7. , 2019

Link: https://doi.org/10.1186/..

10

Multicenter randomized phase II trial of atezolizumab with ..:

Yarchoan, Mark ; Cope, Leslie ; Ruggieri, Amanda N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670844/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Multicenter randomized phase II trial of atezolizumab with ..:

Yarchoan, Mark ; Cope, Leslie ; Ruggieri, Amanda N...
qt3w93z8gj. , 2021

Link: https://escholarship.org..

12

Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RA..:

Dent, Paul ; Booth, Laurence ; Roberts, Jane L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133220/. , 2019

Link: http://www.ncbi.nlm.nih...

13

The irreversible ERBB1/2/4 inhibitor neratinib interacts wi..:

Booth, Laurence ; Roberts, Jane L ; Samuel, Peter...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927661/. , 2018

Link: http://www.ncbi.nlm.nih...

14

The irreversible ERBB1/2/4 inhibitor neratinib interacts wi..:

Booth, Laurence ; Roberts, Jane L ; Avogadri-Connors, Francesca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986350/. , 2018

Link: http://www.ncbi.nlm.nih...

15

Neratinib and entinostat combine to rapidly reduce the expr..:

Booth, Laurence ; Roberts, Jane L ; Sander, Cindy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606002/. , 2018

Link: http://www.ncbi.nlm.nih...